These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27161660)

  • 1. Concise synthesis of calystegines B2 and B3via intramolecular Nozaki-Hiyama-Kishi reaction.
    Wang HY; Kato A; Kinami K; Li YX; Fleet GW; Yu CY
    Org Biomol Chem; 2016 Jun; 14(21):4885-96. PubMed ID: 27161660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of nortropane alkaloid calystegine B
    Underlin EN; Jensen HH
    Carbohydr Res; 2019 Jan; 472():122-126. PubMed ID: 30579118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific alpha-galactosidase inhibitors, N-methylcalystegines--structure/activity relationships of calystegines from Lycium chinense.
    Asano N; Kato A; Miyauchi M; Kizu H; Tomimori T; Matsui K; Nash RJ; Molyneux RJ
    Eur J Biochem; 1997 Sep; 248(2):296-303. PubMed ID: 9346281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and glycosidase inhibitory activity of noeurostegine-a new and potent inhibitor of beta-glucoside hydrolases.
    Rasmussen TS; Jensen HH
    Org Biomol Chem; 2010 Jan; 8(2):433-41. PubMed ID: 20066281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chiral pool synthesis of calystegine A3 from 2-deoxyglucose via a Brown allylation.
    Rasmussen TS; Jensen HH
    Carbohydr Res; 2011 Dec; 346(18):2855-61. PubMed ID: 22088883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calystegine B4, a novel trehalase inhibitor from Scopolia japonica.
    Asano N; Kato A; Kizu H; Matsui K; Watson AA; Nash RJ
    Carbohydr Res; 1996 Oct; 293(2):195-204. PubMed ID: 8938376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of calystegine B2 analogues as glycosidase inhibitors.
    García-Moreno MI; Benito JM; Ortiz Mellet C; García Fernández JM
    J Org Chem; 2001 Nov; 66(23):7604-14. PubMed ID: 11701011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Executing and rationalizing the synthesis of a difluorinated analogue of a ring-expanded calystegine B2.
    Kyne SH; Miles JA; Percy JM; Singh K
    J Org Chem; 2012 Jan; 77(2):991-8. PubMed ID: 22148579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A versatile access to calystegine analogues as potential glycosidases inhibitors.
    Kaliappan KP; Das P; Chavan ST; Sabharwal SG
    J Org Chem; 2009 Aug; 74(16):6266-74. PubMed ID: 19621913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymatic synthesis of the glycosides of calystegines B1 and B2 and their glycosidase inhibitory activities.
    Asano N; Kato A; Kizu H; Matsui K; Griffiths RC; Jones MG; Watson AA; Nash RJ
    Carbohydr Res; 1997 Nov; 304(2):173-8. PubMed ID: 9449768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total synthesis of ent-calystegine B4 via nitro-Michael/aldol reaction.
    Kamimura A; Miyazaki K; Suzuki S; Ishikawa S; Uno H
    Org Biomol Chem; 2012 Jun; 10(22):4362-6. PubMed ID: 22546944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of galacto-noeurostegine and its 2-deoxy analogue as glycosidase inhibitors.
    Salamone S; Clement LL; Viuff AH; Andersen OJ; Jensen F; Jensen HH
    Org Biomol Chem; 2015 Aug; 13(29):7979-92. PubMed ID: 26111992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of calystegines isolated from edible fruits and vegetables on mammalian liver glycosidases.
    Asano N; Kato A; Matsui K; Watson AA; Nash RJ; Molyneux RJ; Hackett L; Topping J; Winchester B
    Glycobiology; 1997 Dec; 7(8):1085-8. PubMed ID: 9455909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological activities of the nortropane alkaloid, calystegine B2, and analogs: structure-function relationships.
    Goldmann A; Message B; Tepfer D; Molyneux RJ; Duclos O; Boyer FD; Pan YT; Elbein AD
    J Nat Prod; 1996 Dec; 59(12):1137-42. PubMed ID: 8988598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docking and SAR studies of calystegines: binding orientation and influence on pharmacological chaperone effects for Gaucher's disease.
    Kato A; Nakagome I; Nakagawa S; Koike Y; Nash RJ; Adachi I; Hirono S
    Bioorg Med Chem; 2014 Apr; 22(8):2435-41. PubMed ID: 24657053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A short synthetic route to the calystegine alkaloids.
    Skaanderup PR; Madsen R
    J Org Chem; 2003 Mar; 68(6):2115-22. PubMed ID: 12636369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-glucosamine trimethylene dithioacetal derivatives: formation of six- and seven-membered ring amino carbasugars. Synthesis of (-)-calystegine B3.
    Chen YL; Redlich H; Bergander K; Fröhlich R
    Org Biomol Chem; 2007 Oct; 5(20):3330-9. PubMed ID: 17912387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A concise stereoselective synthesis of (-)-erycibelline.
    Zhang ZL; Nakagawa S; Kato A; Jia YM; Hu XG; Yu CY
    Org Biomol Chem; 2011 Oct; 9(22):7713-9. PubMed ID: 21946951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calystegine B3 as a specific inhibitor for cytoplasmic alpha-mannosidase, Man2C1.
    Kato A; Wang L; Ishii K; Seino J; Asano N; Suzuki T
    J Biochem; 2011 Apr; 149(4):415-22. PubMed ID: 21217149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective synthesis of the glycosidase inhibitor australine through a one-pot, double-cyclization strategy.
    Ribes C; Falomir E; Carda M; Marco JA
    Org Lett; 2007 Jan; 9(1):77-80. PubMed ID: 17192089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.